Tranche II Prospectus
March 31, 2023
EDELWEISS FINANCIAL SERVICES LIMITED
Edelweiss Financial Services Limited (the "Company" or "Issuer") was incorporated at Mumbai on November 21, 1995 as a public limited company with the name 'Edelweiss Capital Limited' under the provisions of the Companies Act, 1956. Thereafter, a certificate of commencement of business was issued to our Company by the Registrar Of Companies Maharashtra, at Mumbai, ("RoC"), on January 16, 1996. Subsequently, the name of our Company was changed to 'Edelweiss Financial Services Limited' pursuant to a fresh certificate of incorporation issued by the RoC on August 1, 2011. For more information about our Company, please refer "General Information" and "History and Main Objects" on pages 53 and 162 of the Shelf Prospectus and pages 20 and 63 of this Tranche II Prospectus.
Registered Office: Edelweiss House, Off C.S.T. Road, Kalina, Mumbai 400 098, Maharashtra, India; Tel.: +91 22 4009 4400;
Fax: +91 22 4086 3610; CIN: L99999MH1995PLC094641; PAN: AAACE1461E; Website: www.edelweissfin.com; Email: efslncd@edelweissfin.com Company Secretary and Compliance Officer: Mr. Tarun Khurana; Tel.: +91 22 4009 4400; Email: efslncd@edelweissfin.com
Chief Financial Officer: Ms. Ananya Suneja; Tel: +91 22 4009 4400; Email: efslncd@edelweissfin.com
PUBLIC ISSUE BY THE COMPANY OF SECURED REDEEMABLE NON-CONVERTIBLE DEBENTURES OF FACE VALUE OF ₹ 1,000 EACH ("NCDs") OR "DEBENTURES") FOR AN AMOUNT OF ₹ 2000 MILLION ("BASE ISSUE SIZE) WITH AN OPTION TO RETAIN OVERSUBSCRIPTION UP TO ₹ 2000 MILLION AMOUNTING TO ₹ 4000 MILLION ("TRANCHE II ISSUE LIMIT") ("TRANCHE II ISSUE") WHICH IS WITHIN THE SHELF LIMIT OF ₹ 10,000 MILLION AND IS BEING OFFERED BY WAY OF THIS TRANCHE II PROSPECTUS DATED MARCH 31, 2023 CONTAINING INTER ALIA THE TERMS AND CONDITIONS OF TRANCHE II ISSUE ("TRANCHE II PROSPECTUS"), WHICH SHOULD BE READ TOGETHER WITH THE SHELF PROSPECTUS DATED DECEMBER 27, 2022 ("SHELF PROSPECTUS") FILED WITH THE ROC, STOCK EXCHANGES AND SECURITIES AND EXCHANGE BOARD OF INDIA ("SEBI"). THE SHELF PROSPECTUS AND TRANCHE II PROSPECTUS CONSTITUTES THE PROSPECTUS ("PROSPECTUS"). THE ISSUE IS BEING MADE PURSUANT TO THE PROVISIONS OF SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE AND LISTING OF NON-CONVERTIBLE SECURITIES) REGULATIONS, 2021, AS AMENDED (THE "SEBI NCS REGULATIONS"), THE COMPANIES ACT, 2013 AND RULES MADE THEREUNDER AS AMENDED TO THE EXTENT NOTIFIED AND THE SEBI OPERATIONAL CIRCULAR. THE ISSUE IS NOT UNDERWRITTEN.
OUR PROMOTERS
- Mr. Rashesh Shah; Email: efslncd@edelweissfin.com; Tel: +91 22 4009 4400, (ii) Mr. Venkatchalam Ramaswamy; Email: efslncd @edelweissfin.com; Tel: +91 22 4009 4400, (iii) Ms. Vidya Shah; Email: efslncd@edelweissfin.com; Tel: +91 22 4009 4400, and (iv) Ms. Aparna T.C; Email: efslncd@edelweissfin.com; Tel: +91 22 4009 4400. For details of our Promoters, see "Our Promoter" on page 184 of the Shelf Prospectus.
GENERAL RISKS
For taking an investment decision, investors must rely on their own examination of the Issuer and the Issue, including the risks involved. Specific attention of the Investors is invited to the chapters "Risk Factors" on page 18 of the Shelf Prospectus and page 54 of this Tranche II Prospectus, before making an investment in such Issue. This Tranche II Prospectus has not been and will not be approved by any regulatory authority in India, including the Securities and Exchange Board of India ("SEBI"), the Reserve Bank of India ("RBI"), any registrar of companies or any stock exchange in Indian or do they guarantee the accuracy or adequacy of this document.
COUPON RATE, COUPON PAYMENT FREQUENCY, REDEMPTION DATE, REDEMPTION AMOUNT & ELIGIBLE INVESTORS
For details relating to Coupon Rate, Coupon Payment Frequency, Redemption Date, Redemption Amount & Eligible Investors of the NCDs, please refer to the section titled "Issue Related Information" on page 133 of this Tranche II Prospectus.
CREDIT RATING
The NCDs proposed to be issued under the Issue have been rated "CRISIL AA-/Negative (pronounced as CRISIL double A minus rating with Negative outlook)" for an amount of ₹ 10,000 million by CRISIL vide their rating letter dated December 02, 2022, revalidated vide their letter dated February 6, 2023, with rating rationale dated December 01, 2022, and "ACUITE AA-/ Negative (pronounced as ACUITE double A minus)" for an amount of ₹ 10,000 million by Acuité vide their rating letter dated December 07, 2022, revalidated vide their letter dated February 13, 2023, with rating rationale dated December 07, 2022. The ratings given by the Credit Rating Agencies are valid as on the date of this Tranche II Prospectus and shall remain valid until the ratings are revised or withdrawn. The rating is not a recommendation to buy, sell or hold securities and investors should take their own decision. The rating may be subject to revision or withdrawal at any time by the assigning rating agency and each rating should be evaluated independently of any other rating. The rating agency has a right to suspend or withdraw the rating at any time on the basis of factors such as new information. These ratings are not a recommendation to buy, sell or hold securities and Investors should take their own decisions. Please refer to Annexure A and Annexure B of this Tranche II Prospectus for the rating letter, rationale, revalidation and press release of the above rating.
LISTING
The NCDs offered through the Draft Shelf Prospectus, the Shelf Prospectus and this Tranche II Prospectus are proposed to be listed on BSE Limited ("BSE") and BSE shall be the Designated Stock Exchange. Our Company has received an 'in-principle' approval from BSE vide their letter no. DCS/BM/PI-BOND/017/22-23 dated December 20, 2022.
PUBLIC COMMENTS
The Draft Shelf Prospectus dated December 12, 2022 was filed with the BSE, pursuant to the provisions of the SEBI NCS Regulations and was kept open for public comments for a period of seven Working Days (i.e., until 5 p.m.) on December 19, 2022. No comments were received on the Draft Prospectus until 5p.m. on December 19, 2022
LEAD MANAGER TO THE ISSUE | REGISTRAR TO THE ISSUE | DEBENTURE TRUSTEE TO THE ISSUE | |||||
EQUIRUS CAPITAL PRIVATE LIMITED | KFIN TECHNOLOGIES LIMITED | BEACON TRUSTEESHIP LIMITED* | |||||
12th Floor, C Wing, | Selenium Tower-B, | 4 C&D, Siddhivinayak Chambers, | |||||
Marathon Futurex, N.M. Joshi Marg, | Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, | Gandhi Nagar, Opp. MIG Cricket Club | |||||
Lower Parel, Mumbai 400 013 | Serilingampally, Hyderabad - 500 032, Telangana | Bandra (East), Mumbai 400 051 | |||||
Tel: +91 22 4332 0736 | Tel: +91 40 6716 2222 | Tel.: +91 22 26558759 | |||||
Fax: +91 22 4332 0750 | Fax: +91 40 2343 1551 | Email: compliance@beacontrustee.co.in | |||||
Email: efsl.ncd@equirus.com | Email: efsl2.ncdipo@kfintech.com | Website: www.beacontrustee.co.in | |||||
Website: www.equirus.com | Website: www.kfintech.com | Contact Person: Kaustubh Kulkarni | |||||
Contact person: Malay Shah | Contact Person: M Murali Krishna | ||||||
CREDIT RATING AGENCY | STATUTORY AUDITOR | ||||||
S. R. BATLIBOI & CO. LLP | |||||||
12th Floor, The Ruby | |||||||
ACUITÉ RATINGS & RESEARCH LIMITED | CRISIL Ratings Limited | 29 Senapati Bapat Marg | |||||
Dadar (West), | |||||||
708, Lodha Supremus, | CRISIL House, | ||||||
Mumbai 400 028 | |||||||
Lodha iThink Techno Campus, | Central Avenue, Hiranandani Business Park, | ||||||
Maharashtra, India | |||||||
Kanjurmarg (East), Mumbai 400 042 | Powai, Mumbai 400076 | ||||||
Tel: + 91 22 6819 8000 | |||||||
Tel: + 91 22 4929 4000 | Tel: + 91 22 3342 3000 | ||||||
Email: srbc@srb.in | |||||||
Email: chitra.mohan@acuite.in | Fax: +91 22 4040 5800 | ||||||
Contact Person: Shrawan Jalan | |||||||
Website: www.acuite.in | Email: crisilratingdesk@crisil.com | ||||||
Contact Person: Chitra Mohan | Website: www.crisilratings.com | ||||||
Contact Person: Krishna Sitaraman | |||||||
TRANCHE II ISSUE PROGRAMME** | |||||||
TRANCHE II ISSUE OPENS ON: April 6, 2023 | TRANCHE II ISSUE CLOSES ON: April 21, 2023 |
*Beacon Trusteeship Limited under regulation 8 of SEBI NCS Regulations has by its letter dated December 9, 2022 given its consent for its appointment as Debenture Trustee to the Issue and for its name to be included in this Tranche II Prospectus and in all the subsequent periodical communications sent to the holders of the NCDs issued pursuant to the Issue.
-
The Tranche II Issue shall remain open for subscription on Working Days from 10 a.m. to 5 p.m. (Indian Standard Time) during the period indicated in this Tranche II Prospectus, except that the Tranche II Issue may close on such earlier date or extended date (subject to a maximum period of 10 days from the date of opening of Tranche II Issue) as may be decided by the Board of Directors of our Company or the Debenture Fund Raising Committee, thereof, subject to compliance with Regulation 33A of the SEBI NCS Regulations.. In the event of an early closure or extension of the Tranche II Issue; our Company shall ensure that notice of the same is provided to the prospective investors through an advertisement in a daily national newspaper with wide circulation and a regional daily at the place where the registered office of the Company is situated on or before such earlier or extended date of Tranche II Issue closure. Applications Forms for the Tranche II Issue will be accepted only from 10:00 a.m. to 5:00 p.m. or such extended time as may be permitted by BSE, on Working Days during the Tranche II Issue Period. On the Tranche II Issue Closing Date, Application Forms will be accepted only between 10:00 a.m. to 3:00 p.m. and uploaded until 5:00 p.m. (Indian Standard Time) or such extended time as may be permitted by BSE. Further, pending mandate requests for bids placed on the last day of bidding will be validated by 5 PM on one Working Day after the Tranche II Issue Closing Date. For further details please refer to the chapter titled "Issue Related Information" on page 133 of this Tranche II Prospectus.
A copy of this Tranche II Prospectuses shall be filed with the Registrar of Companies, Maharashtra at Mumbai in terms of Section 26 of Companies Act, 2013, along with the endorsed/certified copies of all requisite documents. For further details, please refer to the section titled "Material Contracts and Documents for Inspection" on page 196 of this Tranche II Prospectus.
TABLE OF CONTENTS | |
CERTAIN CONVENTIONS, USE OF FINANCIAL, INDUSTRY AND MARKET DATA AND CURRENCY OF | |
PRESENTATION | 16 |
FORWARD LOOKING STATEMENTS | 19 |
SECTION II - INTRODUCTION | 20 |
GENERAL INFORMATION | 20 |
CAPITAL STRUCTURE | 29 |
OBJECTS OF THE ISSUE | 38 |
STATEMENT OF POSSIBLE TAX BENEFITS | 41 |
MATERIAL DEVELOPMENTS | 54 |
SECTION III - FINANCIAL INFORMATION | 74 |
FINANCIAL STATEMENTS | 74 |
FINANCIAL INDEBTEDNESS | 75 |
SECTION IV - LEGAL AND OTHER INFORMATION | 85 |
OUTSTANDING LITIGATIONS | 85 |
OTHER REGULATORY AND STATUTORY DISCLOSURES | 117 |
SECTION V - ISSUE RELATED INFORMATION | 133 |
ISSUE STRUCTURE | 133 |
TERMS OF THE ISSUE | 140 |
ISSUE PROCEDURE | 159 |
MATERIAL CONTRACTS AND DOCUMENTS FOR INSPECTION | 196 |
DECLARATION | 199 |
ANNEXURE A - CRISIL RATING, RATING RATIONALE, PRESS RELEASE AND REVALIDATION LETTER 200
ANNEXURE B - ACUITE RATING, RATING RATIONALE, PRESS RELEASE AND REVALIDATION LETTER 201 202
203
2
SECTION I - GENERAL
DEFINITIONS AND ABBREVIATIONS
This Tranche II Prospectus uses certain definitions and abbreviations which, unless the context otherwise indicates or implies, shall have the meaning ascribed to such definitions and abbreviations set forth herein. References to any legislation, act, regulation, rules, guidelines, clarifications or policies shall be to such legislation, act, regulation, rules, guidelines, clarifications or policies as amended, supplemented or re-enacted from time to time until the date of this Tranche II Prospectus, and any reference to a statutory provision shall include any subordinate legislation notified from time to time pursuant to such provision.
The words and expressions used in this Tranche II Prospectus but not defined herein shall have, to the extent applicable, the same meaning ascribed to such words and expressions under the SEBI NCS Regulations, the Companies Act, 2013, the SCRA, the Depositories Act and the rules and regulations notified thereunder.
General Terms
Term | Description |
Associates | Associate would mean associates of our Company as at and for the relevant |
financial year/period as applicable. | |
"EFSL" or "Company" or | Edelweiss Financial Services Limited, a public limited company incorporated |
"the Issuer" | under the Companies Act, 1956, and having its Registered Office at Edelweiss |
House, Off C.S.T. Road, Kalina, Mumbai 400 098, Maharashtra, India. | |
"we" or "us" or "our" | Unless the context otherwise requires, this refers to Edelweiss Financial Services |
Limited together with its Subsidiaries, Associates and Trusts for the relevant | |
financial year/period as applicable. | |
Subsidiaries | Subsidiary would mean subsidiaries of our Company as at and for the relevant |
financial year/period as applicable. For the details of the subsidiaries of our | |
Company, as on December 31, 2022, see "Material Developments - History and | |
Main Objects" on page 63 of this Tranche II Prospectus. | |
Trusts | Trust would mean trusts of our Company as at and for the relevant financial |
year/period as applicable. For the details of the trusts of our Company, as on | |
December 31, 2022, see "Material Developments - History and Main Objects" on | |
page 63 of this Tranche II Prospectus. | |
Company Related Terms | |
Term | Description |
Articles or Articles of | Articles of Association of our Company |
Association or AOA | |
Audit Committee | Audit committee of the Board of Directors |
Auditors or Statutory | The current statutory auditors of our Company, M/s. S. R. Batliboi & Co. LLP, |
Auditors | Chartered Accountants |
Board or Board of | Board of Directors of our Company or any duly constituted committee thereof. |
Directors or our Board or | |
our Board of Directors | |
Corporate Social | Corporate Social Responsibility Committee of the Board of Directors |
Responsibility Committee | |
Committee | A committee constituted by the Board, from time to time. |
Debenture Fund Raising | Debenture Fund Raising Committee as constituted by the Board of Directors |
Committee | |
Directors | Directors of the Company |
Equity Shares | Equity shares of the Company of face value of ₹ 1 each |
ESOPs | Employee stock options |
H1 Fiscal 2023 | Half year ended September 30, 2022 |
H1 2023 Unaudited | The unaudited consolidated financial information of the Company for the quarter |
Consolidated Financial | ended September 30, 2022 and year to date April 1, 2022 to September 30, |
Results | 2022 prepared by our Company in the manner and format required by the SEBI |
Listing Regulations |
3
Term | Description |
H1 2023 Unaudited | The unaudited standalone financial information of the Company the quarter ended |
Standalone Financial | September 30, 2022 and year to date April 1, 2022 to September 30, 2022 prepared |
Results | by our Company in the manner and format required by SEBI Listing Regulations |
H1 2023 Unaudited | H1 2023 Unaudited Consolidated Financial Results and H1 2023 Unaudited |
Financial Results | Standalone Financial Results |
Independent Director(s) | The independent director(s) on our Board, in terms of Section 2(47) and Section |
149(6) of the Companies Act, 2013 and SEBI Listing Regulations | |
KMP / Key Managerial | Key managerial personnel of our Company as disclosed in the Shelf Prospectus |
Personnel | and this Tranche II Prospectus and appointed in accordance with Key Managerial |
Personnel, as defined under Section 2(51) of the Companies Act, 2013. | |
LAP | Loan against property |
"MoA" or "Memorandum" | Memorandum of Association of our Company |
or "Memorandum of | |
Association" | |
Nomination and | Nomination and Remuneration Committee of the Board of Directors |
Remuneration Committee | |
Networth | As defined in Section 2(57) of the Companies Act, 2013, as follows: |
"Networth means the aggregate value of the paid-up share capital and all reserves | |
created out of the profits, securities premium account and debit or credit balance | |
of profit and loss account, after deducting the aggregate value of the accumulated | |
losses, deferred expenditure and miscellaneous expenditure not written off, as per | |
the audited balance sheet but does not include reserves created out of revaluation | |
of assets, write back of depreciation and amalgamation." | |
Preference Shares | Preference Shares of the Company having face value of ₹5 each. |
Promoter Group | Includes such persons and entities constituting the promoter group of our Company |
pursuant to Regulation 2 (1) (pp) of the SEBI ICDR Regulations, 2018. | |
Promoters or our Promoter | The promoters of our Company are Mr. Rashesh Shah, Mr. Venkatchalam |
Ramaswamy, Ms. Vidya Shah and Ms. Aparna T.C. | |
Public Issue 1 | Public issue of secured redeemable non-convertible debentures of face value |
₹1,000 each aggregating to ₹2,000 million pursuant to the prospectus dated | |
December 17, 2020. | |
Public Issue 2 | Public issue of secured redeemable non-convertible debentures of face value |
₹1,000 each aggregating to ₹4,000 million pursuant to the prospectus dated March | |
26, 2021. | |
Public Issue 3 | Public issue of secured redeemable non-convertible debentures of face value |
₹1,000 each aggregating to ₹ 4,000 million pursuant to the prospectus dated August | |
9, 2021. | |
Public Issue 4 | Public issue of secured redeemable non-convertible debentures of face value |
₹1,000 each aggregating to ₹ 5,000 million pursuant to the tranche I prospectus | |
dated November 29, 2021. | |
Public Issue 5 | Public issue of secured redeemable non-convertible debentures of face value |
₹1,000 each aggregating to ₹ 4,000 million pursuant to the tranche II prospectus | |
dated September 26, 2022. | |
Public Issue 6 | Public issue of secured redeemable non-convertible debentures of face value |
₹1,000 each aggregating to ₹ 4,000 million pursuant to the tranche I prospectus | |
dated December 27, 2022. | |
Q3 2023 Unaudited | The unaudited consolidated financial information of the Company for the quarter |
Consolidated Financial | ended December 31, 2022 and year to date April 1, 2022 to December 31, 2022 |
Results | prepared by our Company in the manner and format required by SEBI Listing |
Regulations | |
Q3 2023 Unaudited | The unaudited standalone financial information of the Company for the quarter |
Standalone Financial | ended December 31, 2022 and year to date April 1, 2022 to December 31, 2022 |
Results | prepared by our Company in the manner and format required by SEBI Listing |
Regulations | |
Q3 2023 Unaudited | Q3 2023 Unaudited Consolidated Financial Results and Q3 2023 Unaudited |
Financial Results | Standalone Financial Results |
Reformatted Financial | Reformatted Consolidated Financial Information and Reformatted Standalone |
4 |
Term | Description |
Information | Financial Information. |
Reformatted Consolidated | The reformatted consolidated statement of assets and liabilities as at March 31, |
Financial Information | 2022, March 31, 2021, March 31, 2020, the reformatted consolidated statement of |
profit and loss for the year ended 2022, 2021, 2020, the reformatted consolidated | |
statement of cash flows for the year ended 2022, 2021, 2020, the reformatted | |
consolidated statement of changes in equity for the year ended 2022, 2021 and | |
2020. | |
Our audited consolidated financial statements as at and for the year ended March | |
31, 2022, March 31, 2021 and March 31, 2020 form the basis of such reformatted | |
Consolidated Financial Information. | |
Reformatted Standalone | The reformatted standalone statement of assets and liabilities of our Company as |
Financial Information | at March 31, 2022, March 31, 2021, March 31, 2020, the reformatted standalone |
statement of profit and loss for the year ended 2022, 2021, 2020, the reformatted | |
standalone statement of cash flows for the year ended 2022, 2021, 2020, the | |
reformatted standalone statement of changes in equity for the year ended 2022, | |
2021 and 2020. | |
Our audited standalone financial statements as at and for the year ended March 31, | |
2022, March 31, 2021, and March 31, 2020 form the basis of such reformatted | |
Standalone Financial Information. | |
Registered Office | The registered office of our Company is situated at Edelweiss House, Off C.S.T. |
Road, Kalina, Mumbai 400 098, Maharashtra, India. | |
Risk Committee | Risk Committee of the Board of Directors. |
RoC/ Registrar of | Registrar of Companies, Maharashtra at Mumbai. |
Companies | |
Shareholders | The holders of the Equity Shares from time to time. |
Stakeholders' Relationship | Stakeholders' Relationship Committee as constituted by the Board of Directors. |
Committee | |
Total Borrowing(s)/ Total | Debt securities plus borrowings (other than debt securities), subordinated liabilities |
Debt | and deposits. |
Issue Related Terms
Term | Description |
Abridged Prospectus | A memorandum containing the salient features of the Shelf Prospectus and this |
Tranche II Prospectus. | |
Acknowledgement Slip/ | The slip or document issued by the Designated Intermediary to an Applicant as |
Transaction Registration | proof of registration of the Application Form. |
Slip/ TRS | |
Acuité/ Acuite | Acuité Ratings & Research Limited. |
Allotment Advice | The communication sent to the Allottees conveying the details of NCDs allotted to |
the Allottees in accordance with the Basis of Allotment. | |
"Allotment", "Allot" or | Unless the context otherwise requires, the allotment of NCDs to the successful |
Allotted | Applicants pursuant to the Tranche II Issue. |
Allottee(s) | The successful Applicant to whom the NCDs are Allotted either in full or part, |
pursuant to the Tranche II Issue. | |
"Applicant" or "Investor" | Any person who applies for issuance and Allotment of NCDs through ASBA |
process or through UPI Mechanism pursuant to the terms of the Shelf Prospectus, | |
this Tranche II Prospectus, the Abridged Prospectus and the Application Form. | |
"Application" or "ASBA | An application (whether physical or electronic) to subscribe to the NCDs offered |
Application" | pursuant to the Tranche II Issue by submission of a valid Application Form and |
authorising an SCSB to block the Application Amount in the ASBA Account or to | |
block the Application Amount using the UPI Mechanism, where the Bid Amount | |
will be blocked upon acceptance of UPI Mandate Request by retail investors for | |
an Application Amount of upto ₹ 500,000 which will be considered as the | |
application for Allotment in terms of the Shelf Prospectus and this Tranche II | |
Prospectus. |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Edelweiss Financial Services Ltd. published this content on 31 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 April 2023 06:58:05 UTC.